Blockchain Registration Transaction Record

Lexaria Bioscience to Showcase DehydraTECH at BIO 2025

Lexaria Bioscience Corp. to attend BIO 2025, showcasing DehydraTECH® technology for enhanced drug delivery. A leap forward in treating diabetes, hypertension, and more.

Lexaria Bioscience to Showcase DehydraTECH at BIO 2025

Lexaria Bioscience's participation in the BIO International Convention highlights the potential for groundbreaking advancements in drug delivery technology. Their DehydraTECH® platform could revolutionize how medications are absorbed, offering more effective treatments with fewer side effects for conditions like diabetes and hypertension. This development is crucial for patients seeking better therapeutic options and for investors looking for innovative healthcare solutions.

BlockchainDetails
Contract Address0xeA2912a8DA1CD48401b10cB283585874d98098F4
Transaction ID0xe22dcb26534a037352b8d4912003b0f3c3ce523b3467c735dd5203ac6af09d5d
Account0xdBdE7c76e403a5923F3dD4F050Dbbf5c2077BB20
Chainpolygon-main
NewsRamp Digital FingerprintglowYk2D-cb5c7df396e105be98ced83171c71b56